All News

NEW YORK -- The thrombin-specific anticoagulant Angiomax (bivalirudin) as monotherapy in patients acute coronary syndromes reduced the risk of major bleeding by 47% compared with rates for heparin and glycoprotein IIb/IIIa inhibitors, researchers reported.

BOSTON -- Only two types of master cells are needed to build the heart, research teams here have found, apparently simplifying the challenge of using tissue engineering to repair congenital or acquired cardiac damage.

TORONTO -- While stem cells have been widely heralded as holding the keys to the cures of chronic diseases, evidence is mounting that mutated stem cells are at the root of cancer.

BALTIMORE -- A single altruistic kidney donor offering an organ to anyone who needed it stimulated five simultaneous transplants in domino fashion to unrelated HLA-compatible recipients here.

ATLANTA -- Accidental falls account for an estimated 1.8 million annual emergency department visits for older Americans, and falls are the leading cause of trauma deaths in this age group, according to CDC investigators.

WASHINGTON -- In a majority of patients with fibromyalgia, Lyrica (pregabalin) maintains its painkilling effect for several months, a researcher said here.

BOSTON -- Patients with higher plasma levels of docosahexaenoic acid (DHA), a fatty acid found in fish, had a significant 47% reduction in the risk of all-cause dementia and a 39% reduced risk of Alzheimer's, researchers here reported.